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Microcontact printing with aminosilanes: creating
biomolecule micro- and nanoarrays for multiplexed
microfluidic bioassays †
Shivani Sathish,a‡ Sébastien G. Ricoult,a‡ Kazumi Toda-Petersa and Amy Q. Shena∗
Microfluidic systems integrated with protein and DNA micro- and nanoarrays have been the most
sought-after technologies to satisfy the growing demand for high-throughput disease diagnos-
tics. As the sensitivity of these systems relies on the bio-functionalities of the patterned recog-
nition biomolecules, the primary concern has been to develop simple technologies that enable
biomolecule immobilization within microfluidic devices whilst preserving bio-functionalities. To ad-
dress this concern, we introduce a two-step patterning approach to create micro- and nanoarrays
of biomolecules within microfluidic devices. First, we introduce a simple aqueous based microcon-
tact printing (µCP) method to pattern arrays of (3-aminopropyl)triethoxysilane (APTES) on glass
substrates, with feature sizes ranging from a few hundred microns down to 200 nm (for the first
time). Next, these substrates are integrated with microfluidic channels, to then covalently couple
DNA aptamers and antibodies with the micro- and nanopatterned APTES. As these biomolecules
are covalently tethered to the device substrates, the resulting bonds enable them to withstand the
high shear stresses originated from the flow in these devices. We further demonstrated the flexi-
bility of this technique, by immobilizing multiple proteins onto these APTES-patterned substrates
using liquid-dispensing robots to create multiple microarrays. Next, to validate the functionalities of
these microfluidic biomolecule microarrays, we perform (i) aptamer-based sandwich immunoas-
says to detect human interleukin 6 (IL6); and (ii) antibody-based sandwich immunoassays to
detect human c-reactive protein (hCRP) with the limit of detection at 4 nM, a level below the range
required for clinical screening. Lastly, the shelf-life potential of these ready-to-use microfluidic
microarray devices is validated by effectively functionalizing the patterns with biomolecules up to
3 months post-printing. In summary, with a single printing step, this aminosilane patterning tech-
nique enables the creation of functional microfluidic micro- and nano biomolecule arrays, laying
the foundation for high-throughput multiplexed bioassays.
1 Introduction
Since the early 1980’s, microfluidic systems have advanced sig-
nificantly to satisfy the growing demand for the miniaturization
of bioassay devices, with applications ranging from disease diag-
nostics1–4 to cell behavior studies5–8. Here, the main goal has
been to provide cheaper, simpler and more reliable means for si-
multaneous detection of multiple biomarkers, such as DNA and
protein fragments, in a single system9–11. Out of the available
platforms, microarray-based microfluidic bioassay devices are ris-
a Micro/Bio/Nanofluidics Unit, Okinawa Institute of Science and Technology Graduate
University 1919-1 Tancha, Onna-son, Kunigami-gun Okinawa, Japan 904-0495
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ing to the forefront, owing to the ability to achieve multiple
biomarker detection within a single system. This is largely at-
tributed to the fact that multiple recognition biomolecules can be
immobilized in well-defined micro- and nanoarrays on microflu-
idic device substrates, thereby allowing high precision screening
of various biomarkers within a single device12. Although these
systems have several significant advantages, there are several
challenges that impede their routine usage in clinical diagnostics.
First, it has proven to be a major challenge to integrate these mi-
cro/nanopatterned substrates within microfluidic devices, with-
out significantly affecting the functionalities of the immobilized
recognition biomolecules. Additionally, as the flow within the
microfluidic channels generate high shear stresses, the immobi-
lized biomolecules gradually desorb from the surfaces with time.
This in turn proves to be a major drawback, as the reproducibil-
ity of these systems decreases as a result of the inconsistencies in
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the number of available recognition biomolecules in the devices,
throughout the course of the assay. Consequently, it is necessary
to explore new technologies to overcome current limitations of
biomolecule micro- and nanoarray fabrication within microfluidic
devices.
Existing techniques to pattern biomolecules on surfaces in
micro-13 and nanoarrays, include physical patterning approaches
such as photolithography14, adsorption of biomolecules con-
fined to microfluidic networks15, and colloidal lithography16.
These techniques are either plagued by high costs, low through-
put, or limited control over the geometry and functional prop-
erties of the achieved patterns. Particularly, creating nanoar-
rays of biomolecules has been laborious and integration of these
patterned substrates into microfluidic devices has been a chal-
lenge. A recent report proposed a self-assembly-based colloidal
lithography technique to generate nanopatterns which were then
sealed into PDMS microchannels to immobilize proteins onto
the nanoarrays via non-covalent coupling17. Although the pro-
posed method enables the successful generation of multiple pro-
tein nanoarrays within a microfluidic channel, the major draw-
backs are the requirement of complex fabrication techniques to
create the nanopatterned substrates, the repeated fabrication of
new surfaces prior to each use, and the non-covalent coupling of
proteins onto the nanoarrays inducing potential desorption when
subjected to flow.
One of the simpler and preferred methods of patterning micro-
and nanoscale features is microcontact printing (µCP), where
chemical or biological molecules are transferred in designated
patterns from an elastomeric poly(dimethylsiloxane) (PDMS)
stamp onto a substrate with higher surface energy18–21. Although
these microcontact printed biomolecules have been successfully
incorporated into microfluidic devices22,23, several challenges re-
main. First, as patterned biomolecules are physically adsorbed
onto the surfaces driven by hydrogen-bonding and van der Waals
forces24, they are unable to withstand high shear stresses intro-
duced by the flow present in microfluidic channels. As a result,
it gives rise to gradual desorption and degradation of patterned
biomolecules that lead to reduced device performance and poor
shelf life. Secondly, since partial dehydration of biomolecules is a
prerequisite to the µCP technique, the probability of protein de-
naturation and impaired biological activity is high. Additionally,
the lack of control over the orientation of the printed proteins has
been lamented and could be responsible for the suboptimal inter-
actions in bioassays due to the inaccessibility of the binding sites.
Lastly, patterning a substrate with multiple biomolecules proves
to be difficult and time-consuming, as each individual stamp can
only be utilized to pattern a single ink at a time.
To address these challenges, pre-patterned substrates have
been used to covalently link the biomolecules from solution to
pattern sensitive biomolecules. For example, Teerapanich et al.
recently achieved real-time monitoring of protein-binding kinet-
ics by creating patterned gold films to stably and covalently im-
mobilize antibodies within nanofluidic channels25. Others have
reported a simpler and more stable surface patterning technique
that employs covalent coupling of proteins and nucleotides to
silane treated substrates26,27. Recently, Lin et al. demonstrated a
novel method of covalently patterning multiple proteins to a (3-
glycidyloxypropyl)trimethoxysilane modified substrate enclosed
within nanochannels by using a robotic microarray spotter28.
However, alignment of the channels with the patterns is difficult
to achieve since the proteins are deposited onto the substrates
prior to the bonding of the device. Additionally, as the proteins
are dried briefly before alignment, viability for long-term studies
is a concern due to their potential degradation.
Alternatively, (3-aminopropyl)triethoxysilane (APTES), an
amine–NH2 terminated silane can be used to form covalent silox-
ane bonds with silica substrates under pertinent conditions29.
Anhydrous organic solvents like toluene have been widely used
to achieve homogeneity of the formed monolayers and to ensure
covalent binding of APTES with the glass substrates30. These ter-
minal amine groups then serve to covalently couple biomolecules
with the help of appropriate linkers31,32. Several studies have
demonstrated the potential of µCP to create patterns of APTES
monolayers within microfluidic channels that are then covalently
coupled with biomolecules from solution33,34. Although this
method provides simplicity and potential for achieving multiplex-
ing in microfluidic devices, the resolution of obtained features is
not only limited by the microfluidic channel dimensions, but also
by the printing process since existing µCP methods rely on the
use of organic solvents that can potentially swell the PDMS sub-
strate and increase the dimensions of the patterned features35.
Although the degree of PDMS swelling does not significantly af-
fect micron-size features in the stamps, it proves to be a limiting
factor while attempting to achieve nanoarrays of APTES patterns.
Notably, similar to thiols, silanes being small molecules, can dif-
fuse into the PDMS stamp upon long incubation times36. As a
result, during the printing step (on the order of minutes), silane
molecules tend to diffuse out of the stamp along with the solvent
molecules, reducing the resolution of the patterned features37.
In this work, we present a new means of creating micro- and
nanoarrays of aminosilanes within microfluidic devices via an
aqueous based microcontact printing technique to subsequently
create micro- and nanoarrays of biomolecules. To minimize the
diffusion of APTES into the PDMS stamp during the printing pro-
cess, we use water as the inking solvent and enforce short incu-
bation and contact times to preserve the pre-defined resolution of
patterned features38. These patterns then serve as the building
block to couple multiple biomolecules in solution onto a single
surface for subsequent multiplexed bioassays. We verify the mul-
tiplexing capability on a single patterned surface by delivering
different biomolecules to different regions of the patterned ar-
ray with the help of microfluidic networks and liquid dispensing
technologies. Next, to validate the functionality of the coupled
biomolecules, we carry out an aptamer-based immunoassay to
detect interleukin 6 (IL6) and an antibody-based immunoassay
for the detection of human c-reactive protein (hCRP). Finally, we
probe the stability of APTES patterns and demonstrate the possi-
bility of fabricating pre-stored and ready-to-use bioassay devices
with a shelf life of at least 3 months.
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Fig. 1 Fabrication of patterned microfluidic devices. (a) Microcontact printing for APTESaq microarrays: (i) a PDMS stamp inked with APTESaq is
contacted with a plasma activated glass surface through microcontact printing to (ii) transfer APTESaq microarrays (purple) onto the glass surface. (iii)
A PDMS microfluidic channel is then bonded to the patterned glass substrate to create (iv) a sealed microfluidic device encapsulating APTESaq
microarrays. (b) Lift-off nanocontact printing for APTESaq nanoarrays: (i) A plasma-activated NOA63 lift-off stamp was contacted with an
APTESaq–inked flat PDMS stamp. (ii) The APTESaq patterned flat stamp was pressed onto a plasma activated glass slide for 5 s. (iii) A microfluidic
channel was then bonded irreversibly to (iv) encapsulate the nanoarrays.
2 Materials and methods
2.1 Reagents and materials
(3-Aminopropyl) triethoxysilane (APTES), 2-methoxy
(polyethyleneoxy) 6-9 propyl tricholoro silane (PEG-silane)
and Tween 20 were purchased from Nacalai Tesque, Inc., Japan.
1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDC), N-
hydroxysuccinimide (NHS), BS3 crosslinker, phosphate buffered
saline (PBS), HEPES, glycine and streptavidin DyLightTM550
Conjugated, were purchased from Thermo Fischer Scientific,
Japan. Biotin-SP-conjugated AffiniPure goat anti-mouse antibody
was purchased from Jackson ImmunoResearch labs, USA. Bi-
otinylated aptamers specific to interleukin 6 (IL6) were obtained
from BasePair Biotechnologies, USA. Recombinant human IL6
(PHC0066) was purchased from Life Technologies. Mouse anti-c
reactive protein antibody [C5] ab8279 (Abcam, Japan) and
recombinant human c-reactive protein (hCRP) were obtained
from Oriental Yest Co., Ltd., Japan. Alexa Fluor 488 conjugated
chicken anti-goat, Alexa Fluor 546 conjugated rabbit anti-mouse
and goat anti-chicken immunoglobulins (IgGs) were purchased
from Abcam, Japan.
2.2 Patterning and fabrication procedures
2.2.1 Soft lithograhy
Stamps and microfluidic devices were designed with AutoCAD
(AutoDesk, USA). Stamp designs comprised of (i) 100 µm wide
stripes with 100 µm spacing (schematic in Figure 1a(i)), and
(ii) an array of 50 by 50 µm squares (Figure 4a-b) separated
by 50 µm. Three different designs of microfluidic devices were
designed in AutoCAD: (i) 100 µm wide and (ii) 200 µm wide
parallel channels with single inlet, for unidirectional flow; and
(iii) 200 µm wide parallel channels with two different inlets, for
opposite flow directions in alternating channels. More detailed
schematics are illustrated in Figure S1 in the SI document. For
fabricating the master for the devices and stamps, silicon wafers
(4-inch in diameter, E&M Corp. Ltd., Japan) were coated with
a 75 µm layer of mr-DWL 40 photoresist (Microresist technolo-
gies, Germany), and the features were patterned by photolithog-
raphy using a DL1000 maskless writer (NanoSystem Solutions,
Japan) and developed by using mr-Dev 600 developer (Microre-
sist Technologies, Germany). After thorough baking and cleaning,
the wafers were coated with an antiadhesive layer by exposing it
to trichloro(1H, 1H, 2H 2H-perfluorooctyl) silane (Sigma-Aldrich,
Japan) in vapor phase in a desiccator. Microfluidic devices and
stamps with the inverse copy of the pattern present on the Si-
wafer were obtained by pouring 10:1 poly-(dimethylsiloxane)
(PDMS) (DOW Corning, Japan) on the wafer and curing the pre-
polymer for 24 h at 60 ◦C after degassing to remove air bubbles.
For the lift-off nanocontact printing process, flat PDMS stamps
were fabricated by polymerizing the afore mentioned mixture on
a blank Si-wafer.
2.2.2 Microcontact printing (µCP) in microfluidic devices
As illustrated in the schematic in Figure 1a, the micropatterned
stamps were inked with 10 µL of 1% aqueous APTES (APTESaq)
by volume for 1-3 min under a plasma activated coverslip. The
stamps were rinsed with milli-Q water (Millipore, Japan) for 10 s
before rapid drying with a strong pulse of N2 gas. The inked
PDMS stamp was then contacted with a plasma activated (Harrick
Plasma, USA) glass slide for 5 s (Figure 1a(i)-(ii)). The prepared
plasma-activated PDMS microfluidic channel mould was bonded,
perpendicular to the printed substrate to create the microarrays
(Figure 1a(iii)-(iv)). The assembled device was then heated at
85◦C for 5 minutes on a hot plate to simultaneously (a) drive
the formation of a covalent siloxane bond between the reactive
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silanols and the hydroxyl (-OH) groups on the glass substrate39,
and (b) to irreversibly bond the microfluidic device to the sub-
strate.
2.2.3 Nanopatterned lift-off stamps
Nanopatterned PDMS replicas were fabricated using the proto-
col previously described by Ricoult, et al.40. Briefly, nanopat-
terns consisting of a square array (200 nm in length, 200 nm in
width, with 2 µm in spacing) were first created using Clewin Pro
4.0 (Wieweb software, Hengelo, Netherlands). A 4-inch silicon
wafer was coated with PMMA resist and the dot arrays were pat-
terned by electron beam lithography (VB6 UHR EWF, Vistec), fol-
lowed by 100 nm reactive ion etching (System100 ICP380, Plas-
malab) into the Si. After cleaning, the wafer was coated with
an anti-adhesive layer by exposing it to perfluorooctyltriethoxysi-
lane (Sigma-Aldrich, Oakville, ON, Canada) in vapor phase in a
desiccator. An inverse polymer copy of the Si wafer was obtained
after curing PDMS on the patterned wafer as described in the pre-
vious section to generate nanopillars. The lift-off stamp consist-
ing of nanoholes with an inverse copy of the PDMS master (Fig-
ure 3a) was finally obtained by curing Norland Optical Adhesive
63 (NOA63, Norland Products, Cranbury, NJ) on the PDMS stamp
with 600 W of UV light for 40 seconds in a Uvitron 600W UVA
Enhanced Lamp (310-400 nm; 100% intensity) (Uvitron Interna-
tional, Inc., West Springfield, MA). NOA63 is an optically sensitive
adhesive that polymerises on exposure to ultraviolet(UV) light.
2.2.4 Lift-off nanocontact printing
A flat PDMS stamp was inked for 1-3 min with the 1% APTESaq
solution as mentioned above (Figure 1b). After rinsing with
milli-Q water for 10 s, the inked stamps were briefly dried un-
der a stream of N2 and immediately brought into contact with
a plasma activated NOA63 lift-off stamp for 5 s (Figure 1b(i)).
The PDMS was separated from the NOA63 lift-off stamp and the
APTESaq in the contact area were transferred to the NOA63 lift-off
stamp, while the remaining APTESaq molecules were transferred
to the final substrate by printing the PDMS stamp for 5 s onto
a plasma activated glass surface (Figure 1b(ii)). As described in
Section 2.2.2, the plasma-activated PDMS microfluidic channel is
finally bonded to the glass substrate to encapsulate the nanoar-
rays (Figure 1b(iii)-(iv)) and heated at 85◦C for 5 minutes on a
hot plate (Figure 1b(iii)-(iv)).
2.3 APTESaq–biomolecule grafting within patterned devices
Following APTESaq patterning and device assembly, the un-
patterned regions within the device were blocked for 30 min by
flowing a solution of 2 wt% PEG-silaneaq through the device.
Flow rates of 2 µL/min were used to pump fluids through the
channels for all experiments described below. Additionally, the
unreacted molecules were washed out of the channels by flowing
a wash buffer that consisted of 1×PBS (phosphate buffer saline)
mixed with 0.05% Tween 2041, for 10 minutes after every step
of the reaction in all the experiments. Fluorescently labelled im-
munoglobulins or protein of interest at 10 µg/ml were flowed
through the channels for 30 minutes to covalently graft the pro-
teins on the APTESaq patterned surface by employing EDC-NHS
chemistry at a 10–fold molar excess of EDC (2 µM) and NHS
(5 µM) to protein (see Figure 2a & b). Similarly, DNA aptamers
were grafted using BS3 (bis(sulfosuccinimidyl)suberate) chem-
istry where 100 µM of BS3 in milli-Q water was flowed over the
patterns for 30 mins in the device to enable reaction with the
available terminal amine (–NH2) group on the APTESaq, followed
by the aptamer solution (10 µg/ml) in 20 mM HEPES buffer for
30 mins and 50 mM of Glycineaq to quench unreacted BS3 for
an additional 30 mins. Unreacted components were washed with
wash buffer (0.05% Tween 20 in 1× PBS) following each step of
the reaction.
2.4 Immunoassay
For the aptamer-based immunoassay, 10 µg/ml of –NH2-
terminated aptamers specific to interleukin 6 (IL6) were grafted
onto the APTESaq microarrays via BS3 chemistry after blocking
(Section 2.3). Flow rates of 2 µL/min were used to deliver the
solutions through the channels for all steps of the experiments de-
scribed below. Subsequently, 470 nM of IL6 was flowed through
the channels for 30 mins and detected with the help of a compli-
mentary biotinylated detection aptamer (10 µg/ml) and strepta-
vidin dye that were flowed through the same channels for 30 mins
each. To carry out an antibody-based sandwich immunoassay
to detect c-reactive protein (hCRP), capture antibodies against
hCRP were grafted onto APTESaq microarrays via BS3 chem-
istry (Section 2.3). Varying concentrations from 2 nM to 217
nM of hCRP mixed in 1×PBS were flowed through microchan-
nels of different devices patterned with capture antibodies against
hCRP for 30 mins respectively. The reaction was detected by a
detection antibody pair that consisted of the same capture an-
tibodies and complimentary Alexa-fluor 546-labelled fluorescent
secondary antibodies (10 µg/ml), see detailed schematic in Fig-
ure 5b. Given the pentameric structure of hCRP, the same capture
antibody was used as the detection antibody at a concentration of
10 µg/ml, flowed for 30 mins through the microchannels. Unre-
acted components were washed with wash buffer (0.05% Tween
20 in 1× PBS) for 10 mins, following each step of the reaction.
The flow rates and incubation times used in this work were se-
lected to demonstrate proof-of-concept immunoassay reactions,
and can be further optimized as per immunoassay requirements.
2.5 Imaging and analysis
NOA63 lift-off stamps were imaged using Quanta 250 FEG scan-
ning electron microscope (FEI, Japan) at 5 kV with a spot size of
3.5 using an ETD Detector to detect secondary electrons. Micro-
and nanopatterns of fluorescently labeled protein were imaged
on a Ti-E Eclipse inverted fluorescent microscope (Nikon, Japan)
and an LSM 780 Confocal microscope (Zeiss, Japan). All images
were captured with fixed exposure times within each experiment,
which varied from 1 to 10 s for all the images shown in this work.
Mean fluorescence intensity measurements were obtained by per-
forming image analysis in ImageJ (NIH, USA). Images were pro-
cessed post quantification to increase the contrast through linear
modifications in ImageJ.
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3 Results and discussions
Fig. 2 Microarrays of IgGs and DNA aptamers in APTESaq
patterned microfluidic devices. (a) Biotinylated IgGs were grafted on
the APTESaq patterns via EDC-NHS chemistry and labeled with
fluorescent streptavidin dye (in red) to reveal an array of 100 µm
squares within the microfluidic channels. (b) Alternatively,
amine-terminated biotinylated primary aptamers (1◦ aptamer) were
immobilized to the APTESaq microarray via BS3 chemistry and
subsequently stained with streptavidin dye. Dotted lines depict
microfluidic channel boundaries and scale bars are 200 µm. Illustrations
portray the binding architecture of molecules within the patterns.
3.1 APTESaq microarrays for grafting of biomolecules within
microfluidic devices
A microcontact printing process was developed to print microar-
rays of aqueous APTES (APTESaq) in closed microfluidic devices.
These APTES micropatterns then serve to covalently couple vari-
ous types of biomolecules to subsequently create the biomolecule
microarrays within the microfluidic devices. As described in Sec-
tion 2.3, APTESaq was printed in microarray geometries, enclosed
within the horizontal microfluidic channels (schematic in Fig-
ure 1a) and covalently coupled with the desired biomolecules.
Here, 2% PEG-silaneaq was used to block non-specific sites since
it not only acts as a non-biofouling agent but also prevents diffu-
sion of APTESaq on the patterned substrate.
Figure 2a & b depict grafting of biotinylated immunoglobulins
(IgGs) via EDC–NHS chemistry and amine (–NH2)-terminated bi-
otinylated aptamers using BS3 (bis(sulfosuccinimidyl)suberate),
an –NH2 to –NH2 linker, onto APTES patterns respectively. These
patterned biotinylated molecules were then subsequently labeled
with fluorescent streptavidin dye to reveal their successful cova-
lent grafting as red squares within the microfluidic channels. Ad-
ditionally, the integrity of the biomolecule patterns under high
shear stresses in the microfluidic channels was confirmed as
shown in Supplementary Figure S2.
In previously described methods34, when the silanes were
inked with toluene, there is a high probability of PDMS swelling
and subsequent change in feature sizes. Additionally, silane-
toluene reservoirs are created within the stamp, which diffuse
out of the stamp when printed onto glass surfaces for long con-
tact times,37 ultimately leading to loss of resolution. With our
protocol, by using water as the inking solvent, we not only limit
the probability of silane reservoir formation and swelling of the
stamp, but also reduce leakage upon contact by using combined
inking and printing times on the order of a few minutes. Thus, the
desired patterning dimension is maintained during and after the
printing process, a prerequisite for high-efficiency microarray ap-
plications. These results depict the compatibility of this technique
with glass-based microfluidic devices to create microarrays of not
only proteins but also effectively couple other biomolecules such
as DNA aptamers covalently onto their substrates for subsequent
bioassay applications.
3.2 Aminosilane nanoarrays for biomolecule immobilization
within microfluidic devices
In addition to successfully creating microarrays of APTES to co-
valently pattern biomolecules, we further demonstrate a sim-
ple lift-off nanocontact printing method for creating nanoarrays
of APTESaq within microfluidic channels to subsequently graft
biomolecules covalently. Generally, PDMS stamps with pillars of
desired shapes are employed for the microcontact printing pro-
cess. These pillars are of microscale dimensions and are less sus-
ceptible to collapse when pressed onto a substrate. Therefore,
the patterned features are intact after transfer. However, if the
dimensions of the pillars are reduced down to the nanoscale,
the pillars are highly susceptible to collapse when pressed onto
the substrate. This in turn leads to loss of resolution of de-
sired nanoscale features42. Hence, to pattern high resolution
arrays with nanometer scale geometries, the use of patterned
stamps with nanopillars was avoided. Alternatively, a two-stamp
process utilizing NOA63 lift-off stamps (Figure 3a) and PDMS
flat stamps, was employed to pattern nanoarrays of APTESaq on
glass substrates of microfluidic devices. Here, the final pattern is
printed using a flat PDMS stamp to avoid loss of resolution (Sec-
Fig. 3 Lift-off nanocontact printing for APTES nanoarrays. (a) SEM
image depicting the nanoholes on the surface of an NOA63 lift-off
stamp. (b) Confocal microscopy image of fluorescently-labeled IgGs
grafted onto the APTESaq nanoarrays within the microfluidic channels.
The illustration depicts the binding architecture within patterns. Scale
bars in (a) & (b) are 5 µm and 500 nm in the inset of (b).
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Fig. 4 Multiplexed protein microarrays on APTESaq micropatterns using liquid dispensing robots and microfluidic devices. (a) Schematic
illustrating a liquid dispensing robot delivering two different protein solutions to different portions of an APTESaq patterned substrate. (b) A liquid
dispensing robot was used to locally deliver EDC–NHS activated Alexa-fluor 488 (green) and 546-labelled fluorescent antibodies (red) to different
regions of an APTESaq array blocked with PEG-silaneaq. (c) Microcontact printing of an array of 100 µm wide APTESaq stripes was carried out prior to
bonding of a microfluidic device containing channel arrays that were aligned perpendicular to each other. (d) Blocking was carried out using
PEG-silaneaq prior to delivering solutions of fluorescently-labeled IgGs to alternating channels. After washing, a microarray of alternating patterns of
red and green-labeled IgG are created within the microfluidic channels. Scale bars are 2 mm in (b), 300 µm in the insets of (b), and 300 µm in (d).
tion 2.2.4). Subsequently, fluorescently-labeled IgGs were grafted
onto the APTESaq nanopatterns via EDC-NHS chemistry to reveal
200 nm nanoarrays of proteins within the microfluidic channels
(Figure 3b).
Several prior studies have reported the potential of nanocon-
tact printing for the creation of biomolecule nanoarrays. How-
ever, few reports have incorporated these patterns into microflu-
idic devices for subsequent microfluidic bioassays17. Additionally,
the reliance of the nanocontact printing process on physisorption
proves to be a drawback, as the biomolecules are susceptible to
detachment from the surface due to the presence of high shear
stress introduced by the flow. Our new protocol here addresses
all these challenges: by employing lift-off nanocontact printing of
APTESaq on glass substrates, covalently tethered nanopatterns of
proteins with a resolution of 200 nm can be easily integrated into
microfluidic devices. Additionally, these protein nanopatterns are
created with the same efficiency as the previously described di-
rect nanocontact printing approach by Ricoult, et al.40, see more
details in Figure S3 of the SI document. Although DNA nanoar-
rays have been used over the years for various applications in the
field of genomics for high-throughput DNA screening43,44, there
are fewer technologies that utilize protein nanoarrays in microflu-
idic platforms for disease diagnostics. This is mainly attributed to
the difficulties in creating robust protein nanoarrays45 within mi-
crofluidic devices. Addressing this major challenge, our newly
developed technique can create robust, cheap and simple multi-
plexed microfluidic nanoarrays that will enable high-throughput
protein and DNA detection with high reproducibility and ease.
3.3 Multiplexing on aminosilane microarrays
Although microcontact printing has been widely used for the
creation of biomolecule microarrays46, it has proven to be a
daunting task to pattern multiple biomolecules on a single sub-
strate with this technique. To overcome the one stamp–one ink
characteristic of microcontact printing, we use APTESaq microar-
rays to capture and covalently graft different locally delivered
biomolecules. To visually demonstrate the capability of pattern-
ing multiple biomolecules onto a single surface, two different so-
lutions of EDC–NHS activated Alexa-fluor 488 (green) and 546-
labelled fluorescent antibodies (red) were delivered onto the pat-
terned substrate by two modes of liquid delivery. First, an array
of squares (50 by 50 µm) of APTESaq was patterned on a plasma
activated glass slide by microcontact printing and blocked with
2% PEG-silaneaq. Liquid dispensing robots (Musashi Engineering,
Japan) were then used to deliver microliter volumes of droplets
containing the two protein solutions (Figure 4a) to achieve a mi-
croarray composed of multiple biomolecules on the patterned sur-
face (Figure 4b).
Alternatively, microfluidic devices (Figure 4c) with channel ar-
rays were bonded on an array of 100 µm wide APTESaq stripes
aligned perpendicular to the direction of the microfluidic chan-
nels. After blocking with PEG-silaneaq, the two solutions of EDC-
NHS activated fluorescently-labeled antibodies (red and green)
were fed into the channels and covalently grafted onto the
APTESaq patterns within the channels (Figure 4d).
One of the major obstacles in achieving multipatterning by mi-
crocontact printing has been the necessity of fabrication of com-
plex stamps that either contained microfluidic circuits or gradient
generators on the stamp to create patterned concentration gradi-
ents on substrates. In comparison, the aminosilane printing ap-
proach coupled with microfluidics introduced in this work, facili-
tates the creation of large and stable arrays composed of multiple
biomolecules presented via covalent bonds in a single device. By
making use of the localized delivery available in microfluidic de-
vices or liquid dispensing platforms, multi-protein patterns could
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Fig. 5 Aptamer and antibody-based immunoassay in APTESaq patterned devices. (a) Aptamer-based sandwich immunoassays (via primary
capture aptamers (1◦ aptamer) and secondary detection aptamers (2◦ aptamer)), and (b) antibody-based immunoassays (via primary capture
antibodies (anti-CRP) and secondary detection antibody pairs (anti-CRP and 2◦ antibody)) were carried out to detect of IL6 and hCRP on
aptamer-functionalized and antibody-functionalized APTESaq microarrays respectively in microfluidic devices. (c) Histogram of normalized
fluorescence intensity values is plotted for detection of 4 nM of hCRP versus that of blank and negative control (IL6). (d) Normalized fluorescence
intensity values are plotted for the tested concentrations of hCRP. The red solid line depicts the best curve fit and the dotted blue lines depict the limit
of detection where the lowest concentration of hCRP detected was 4 nM. Scale bars are 100 µm for (a) & (c) and 200 µm for (b).
easily be achieved within a single array. Additionally, with the ad-
vent of nanofluidic devices47 and liquid dispensing robots deliv-
ering picolitre droplets, densely packed nanoarrays can undoubt-
edly be achieved in the near future.
3.4 Aptamer-based and antibody-based immunoassays
To test the sensitivity and validate biofunctionality of our
APTESaq-micropatterned microfluidic devices, sandwich-based
immunoassays were carried out to detect interleukin 6 (IL6) and
human c-reactive protein (hCRP) with the help of either aptamers
or antibodies respectively. IL648,49 and hCRP50,51 are the most
important biomarkers of neurological, cardiovascular and other
pathophysiological conditions that arise from tissue inflammation
or infection. Quantitative detection of these biomarkers has im-
mensely helped in early diagnosis and treatment of these diseases.
In order to accurately diagnose these diseases, sensitive assays
and biosensing technologies are required to reliably detect minute
quantities of these biomarkers52–54. Therefore, to test the func-
tionalities of our microarray microfluidic devices, aptamer and
antibody-based immunoassays were performed to qualitatively
and quantitatively detect IL6 and hCRP.
Aptamer-based immunoassays were carried out using the pro-
tocol described in Section 2.4 to succesfully detect 470 nM of
IL6 (Figure 5a). Next, to detect hCRP, an antibody-based sand-
wich immunoassay was carried out on APTESaq microarrays in
microfluidic devices (Figure 5b). To further characterize the sen-
sitivity of these patterned devices, we focused on the antibody-
based sandwich immunoassay. A range of concentrations of hCRP
from 4–200 nM was successfully detected via the detection anti-
body pair and qualitatively analyzed by fluorescence microscopy
(more details are shown in Figure S4a-e in the SI document).
To estimate the detection of hCRP quantitatively, the normal-
ized fluorescence intensity was calculated for each condition by
measuring the ratio of mean pixel intensity of the patterned re-
gion (red) to that of the unpatterned region (black), averaged
over 3 images each with 9 patterned squares in each image. A
blank reaction was carried out by flowing the detection antibody
pair over the grafted capture antibody to account for the non-
specific adsorption. The histogram in Figure 5c depicts the nor-
malized fluorescence intensity plotted for positive detection of the
lowest detectable concentration of 4.4 nM of hCRP versus that of
the blank reaction and a negative control (i.e., IL6 flowed through
the anti-hCRP grafted microchannels). Since the same primary
antibody was used as both the capture and detection antibodies,
it is likely to be responsible for the non-specific adsorption ob-
served in these devices.
Figure 5d displays the normalized fluorescence intensity val-
ues captured for each concentration of hCRP detected (in black
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squares), while the solid red line is the best linear curve fit55 with
an R2 value of 0.922. Results illustrate that the lowest detectable
concentration of hCRP in these patterned devices was 4 nM as
estimated by the limit of detection calculated to be 1.67 relative
fluorescence units (RFU), derived from the following formula56:
LoB=Meanblank+1.645(SDblank), (1)
LoD= LoB+1.645(SDlcs) (2)
where LoB, SD, LoD and lcs are the limit of blank, standard of
deviation, limit of detection and lowest concentration sample re-
spectively.
The successful detection of clinically significant levels of IL6
and hCRP validates the biofunctionality of these patterned de-
vices. The sensitivity of these devices can be significantly im-
proved in the future with more specific aptamer or antibody com-
binations coupled with label-free detection systems.
3.5 Stability of aminosilane microarrays
To assess the stability of the APTESaq microarrays, microfluidic
device substrates were pre-patterned with APTESaq by microcon-
tact printing perpendicular to the microfluidic channels, in stripes
of 100 µm separated by 100 µm in spacing. Thirty patterned
and sealed devices were stored in plastic containers after block-
ing with PEG-silaneaq for up to 3 months at room temperature
(25◦C) or at 4◦C in the absence of vacuum. Three devices per
testing condition were characterized to determine the efficiency
of grafting of fluorescently labeled IgGs (immunoglobulins) on
the APTESaq microarrays.
Square fluorescent bands shown in Figure 6a-f illustrate suc-
cessful grafting of the IgGs. To quantify the efficiency of grafting,
fluorescent squares were considered as signal and unpatterned
regions as background. Normalized fluorescence intensity values
were quantified by ImageJ using the same method of analysis as
previously described, and plotted for each of the testing condi-
tions (3 devices per condition) (Figure 6g), where the standard
deviations indicate averaging uncertainty. Figure 6 demonstrates
that the APTESaq is stable for 3 months when stored at either 4◦C
or 25◦C and can be used to graft biomolecules prior to immunoas-
say to eliminate the concern of biodegradation arising from the
storage of patterned biomolecules.
It is worth noting that the initially microcontact printed
APTESaq patterns already have a small level of inhomogeneity
as seen in Figure 6a & d. This may be due to the oligomerization
of highly reactive APTESaq molecules in water that form aggre-
gates when inked on the stamp before the printing process57,58.
This can be reduced by preparing fresh aqueous APTESaq solution
prior to the inking process, reducing inking times and eliminating
the step where the inked stamp is rinsed with water prior to print.
Although the presence of fluorescently-labelled IgGs on devices
stored for 3 months depicts presence of APTESaq (Figure 6g),
gradual degradation of APTESaq is seen with time (Figure 6c & f).
As elucidated in previous literature59 this degradation could be
either owing to (i) moisture aided decomposition of APTESaq 60
due to the high humidity environment present while performing
Fig. 6 APTESaq microarrays in microfluidic devices are stable for
90 days at both 4◦C and room temperature. Fluorescently labeled
IgGs (green) were grafted on Day 1, Month 1 and Month 3 onto 6
different APTESaq–patterned microfluidic devices stored at 4◦C ((a), (b)
& (c)) and at 25◦C ((d), (e) & (f)) respectively. (g) The histogram depicts
the normalized fluorescence intensity, quantified on the APTESaq
patterns for three tested conditions. Scale bars are 100 µm.
the experiments, (ii) gradual self –NH2-catalyzed hydrolysis and
removal of the covalent siloxane of APTESaq 39, or (iii) incom-
plete covalent binding of APTESaq to the glass substrate30. Ad-
ditionally, an increase in normalized fluorescence intensities was
observed for the devices grafted on month 1 versus month 3 when
stored at 4◦C. This is potentially caused by the presence of large
number of IgG aggregates in the devices grafted on month 3 as
seen in Figure 6c. These aggregates contribute significantly to the
average fluorescence signals, thereby leading to an increase in the
normalized intensity.
By printing aminosilane microarrays that are insensitive to en-
zymes and subsequently capturing the biomolecules at the time
of the bioassay, we highlight the following advantages: 1) the
patterned substrates can be stored on the order of months be-
fore carrying out the bioassay, 2) biomolecules are less likely
to be affected by denaturation associated with external stresses
since they are delivered in solution, and 3) interaction sites can
be accurately engineered by precisely designing the silanes and
biomolecules thereby providing control over the orientation of
the biomolecules. Additional experiments are being carried out
to further probe and improve the homogeneity and chemical via-
bility of APTESaq microarrays on substrates upon storage, which
will be reported in the future.
4 Conclusions
To create biomolecular micro- and nanoarrays within microflu-
idic channels, we introduced a micro- and nanocontact printing
method to pattern amino terminated silanes on a desired planar
surface, with feature sizes ranging from a few hundred microns
down to 200 nm. This protocol provides several key advantages.
First, owing to its compatibility with PDMS, water can be used as
the inking solvent to pattern APTES arrays onto glass substrates.
Next, the microfluidic channels deliver a blocking solution, to (i)
limit the diffusion of volatile silanes as well as (ii) inhibit biofoul-
ing. APTES micro- and nanoarrays can be grafted with different
biomolecules such as proteins and DNA in controlled orientations
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for subsequent immunoassay applications within these devices.
Additionally, the APTESaq microarrays maintain their ability to co-
valently graft biomolecules to the surface for at least 3 months af-
ter printing with no significant difference between storage condi-
tions at room temperature or at 4◦C, thereby demonstrating their
storage potentials. By grafting biomolecules onto pre-patterned
substrates prior to use, it greatly preserves the functionalities of
the grafted biomolecules with minimized risks of biodegradation,
accompanied by simplified operation protocols.
To demonstrate the multiplexing potentials of this technology,
localized delivery available in microfluidic devices or liquid dis-
pensing platforms were used to achieve multi-protein pattern-
ing within a single array. By exhibiting successful DNA-based
immunoassays and antibody-based immunoassays carried out on
microcontact printed aminosilane microarrays, we validated the
biofunctionality of these devices thereby elucidating the overall
potential of this technology in the field of bioassay applications.
Applications for biomolecule micro- and nanoarrays are
broad43,61,62, but their translation from the lab to commercial
products has been hindered by limited abilities to integrate micro-
and nanoscale patterns into microfluidic devices with high preci-
sion. With our simple patterning technique, robust micro- and
nanoarrays of different biomolecules can be created with ease
within microfluidic devices for next-generation high-throughput
biomarker detection.
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Figure: Aqueous based microcontact printing (μCP) to create micro- and nanoarrays of (3-
aminopropyl)triethoxysilane (APTES) on glass substrates of microfluidic devices for covalent 
immobilization of DNA aptamers and antibodies. 
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